Search

Author/Creator Coveler, Andrew L

3. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Issue 5 (May 2023)

Authors:
Strickler, John H; Cercek, Andrea; Siena, Salvatore; André, Thierry; Ng, Kimmie; Van Cutsem, Eric; Wu, Christina; Paulson, Andrew S; Hubbard, Joleen M; Coveler, Andrew L; Fountzilas, Christos; Kardosh, Adel; Kasi, Pashtoon M; Lenz, Heinz-Josef; Ciombor, Kristen K; Elez, Elena; Bajor, David L; Cre...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 5(2023)
Page Start:
496
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search